Puma Biotechnology, Inc. (PBYI)
9.55
+0.14
(+1.49%)
USD |
NASDAQ |
Sep 04, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Price to Book Value : 3.523 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 3.523 |
| September 03, 2026 | 3.471 |
| September 02, 2026 | 3.574 |
| September 01, 2026 | 3.449 |
| August 31, 2026 | 3.360 |
| August 28, 2026 | 3.342 |
| August 27, 2026 | 3.408 |
| August 26, 2026 | 3.379 |
| August 25, 2026 | 3.438 |
| August 24, 2026 | 3.364 |
| August 21, 2026 | 3.408 |
| August 20, 2026 | 3.360 |
| August 19, 2026 | 3.500 |
| August 18, 2026 | 3.408 |
| August 17, 2026 | 3.253 |
| August 14, 2026 | 3.257 |
| August 13, 2026 | 3.213 |
| August 12, 2026 | 3.283 |
| August 11, 2026 | 3.235 |
| August 10, 2026 | 3.205 |
| August 07, 2026 | 3.286 |
| August 06, 2026 | 2.995 |
| August 05, 2026 | 2.947 |
| August 04, 2026 | 2.877 |
| August 03, 2026 | 2.836 |
| Date | Value |
|---|---|
| July 31, 2026 | 2.925 |
| July 30, 2026 | 2.910 |
| July 29, 2026 | 2.881 |
| July 28, 2026 | 2.940 |
| July 27, 2026 | 2.947 |
| July 24, 2026 | 2.944 |
| July 23, 2026 | 2.954 |
| July 22, 2026 | 2.903 |
| July 21, 2026 | 3.165 |
| July 20, 2026 | 3.062 |
| July 17, 2026 | 3.146 |
| July 16, 2026 | 3.098 |
| July 15, 2026 | 3.102 |
| July 14, 2026 | 3.054 |
| July 13, 2026 | 2.980 |
| July 10, 2026 | 2.951 |
| July 09, 2026 | 2.914 |
| July 08, 2026 | 2.999 |
| July 07, 2026 | 2.936 |
| July 06, 2026 | 3.032 |
| July 02, 2026 | 3.047 |
| July 01, 2026 | 2.947 |
| June 30, 2026 | 2.991 |
| June 29, 2026 | 3.245 |
| June 26, 2026 | 3.213 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Arcutis Biotherapeutics, Inc. | 13.61 |
| ACADIA Pharmaceuticals, Inc. | 3.691 |
| Alnylam Pharmaceuticals, Inc. | 26.28 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
Price to Book Value Related Metrics
| PE Ratio | 18.50 |
| PS Ratio | 2.126 |
| Price to Free Cash Flow | 11.94 |
| Price | 9.55 |
| Earnings Yield | 5.41% |
| Market Cap | 488.03M |
| Operating PE Ratio | 16.15 |
| Normalized PE Ratio | 18.49 |